Experienced in Liver Failure
Experienced in Liver Failure
3320 Old Jefferson Road, Bldg 200, 
Athens, GA 

Overview

Narayana Gowda is a Pulmonary Medicine provider in Athens, Georgia. Dr. Gowda is rated as an Experienced provider by MediFind in the treatment of Liver Failure. His top areas of expertise are Obstructive Sleep Apnea, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, and Bone Marrow Aspiration. Dr. Gowda is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 60 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Ucla, Sleep Medicine, 2023
Residency
Augusta University, Internal Medicine, 2018
Specialties
Pulmonary Medicine
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine - Critical Care Medicine
American Board Of Internal Medicine - Pulmonary Disease
American Board Of Internal Medicine - Sleep Medicine
Fellowships
UCLA David Geffen School of Medicine/UCLA Medical Center, Sleep Medicine, 2023
Medical College of Georgia, Pulmonary/Critical Care, 2022
Hospital Affiliations
St Mary's Hospital
Piedmont Athens Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser
  • EPO
  • HMO
  • POS
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Athens Pulmonary and Sleep Medicine
3320 Old Jefferson Road, Bldg 200, Athens, GA 30607

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


60 Clinical Trials

A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
View 42 Less Clinical Trials
Similar Doctors
Alexander Gluzman
Distinguished in Liver Failure
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Liver Failure
Pulmonary Medicine | Intensive Care Medicine

Piedmont Physicians Pulmonary And Sleep Medicine Buckhead

275 Collier Road NW, Suite 300, 
Atlanta, GA 
 (57.0 miles away)
Languages Spoken:
English, Russian
Accepting New Patients
Offers Telehealth

Alexander Gluzman, M.D., earned his medical degree from Medical College of Georgia in Augusta, Ga. He completed his residency and pulmonary and criticalcare training at Emory University. He received his undergraduate degree from Emory University. Prior to joining Piedmont Physicians, Dr. Gluzman was in practice with Georgia Lung Associates. Dr. Gluzman has been practicing medicine for 10 years. He holdsboard certifications in critical care medicine, pulmonary disease and internal medicine. Dr. Gluzman specializes in advanced bronchoscopy techniques such as EBUS and electromagnetic navigational bronchoscopy. He will be providing intensive care coverage at Piedmont Atlanta, and is fluent in Russian. In his spare time, Dr. Gluzman enjoys spending time with family, reading and traveling. Dr. Gluzman welcomes new patients and accepts most insurance plans. Dr. Gluzman is rated as a Distinguished provider by MediFind in the treatment of Liver Failure. His top areas of expertise are Lung Metastases, Bronchogenic Cyst, Pneumonia, Gastrostomy, and Advanced Bronchoscopy.

Craig Patterson
Advanced in Liver Failure
Pulmonary Medicine | Intensive Care Medicine
Advanced in Liver Failure
Pulmonary Medicine | Intensive Care Medicine

Piedmont Physicians Pulmonary And Sleep Medicine Buckhead

275 Collier Road NW, Suite 300, 
Atlanta, GA 
 (57.0 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Craig M. Patterson, M.D., completed his fellowship at the Louisiana State University Health Sciences Center and the Ochsner Clinic Foundation in New Orleans, La. During his post-graduate training, he was selected as the inaugural Russell C. Klein Visiting Fellow for the LSUHSC Global Pulmonary Exchange Program with Ege University in Izmir, Turkey. He previously completed a residency in internal medicine at the University of Alabama at Birmingham and medical school at the Louisiana State University School of Medicine in New Orleans. He is a proud graduate of Texas A&M University in College Station, Texas and an Eagle Scout. Before joining Piedmont Physicians, Dr. Patterson was in practice with Georgia Lung Associates. He is board-certified in pulmonary disease, critical care medicine, and internal medicine. His professional interests include pulmonary hypertension, venous thromboembolic disease, and critical care medicine. He is a member of the American College of Chest Physicians and a participant in the ACCP's Pulmonary Vascular Disease One Network. Dr. Patterson enjoys cooking and travel. He is an avid fan of college athletics, marathon runner, husband, and father to twin boys. Dr. Patterson welcomes new patients and accepts most insurance plans. Dr. Patterson is rated as an Advanced provider by MediFind in the treatment of Liver Failure. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hypertension, Gastrostomy, and Endoscopy.

James Chang
Advanced in Liver Failure
Intensive Care Medicine | Pulmonary Medicine
Advanced in Liver Failure
Intensive Care Medicine | Pulmonary Medicine

Piedmont Physicians Pulmonary And Sleep Medicine Buckhead

275 Collier Road NW, Suite 300, 
Atlanta, GA 
 (57.0 miles away)
Languages Spoken:
English, Korean
Accepting New Patients
Offers Telehealth

James W. Chang, DO, FCCP, received his undergraduate degree from University of California, San Diego. He earned his medical degree from Philadelphia College of Osteopathic Medicine, Georgia Campus. He completed his internal medicine residency at Michigan State University and pulmonary and critical care medicine fellowship at Case Western Reserve University in Cleveland, Ohio. Dr. Chang is board certified in internal medicine, pulmonary disease and critical care medicine. Dr. Chang has presented at national conferences and published in peer-reviewed journals. He is a member of the American Thoracic Society, American College of Chest Physicians and the Society of Critical Care Medicine.Dr. Chang specializes in pulmonary disease and critical care medicine. He has special interests in asthma, COPD, bronchiectasis, lung nodules and lung cancer. He performs advanced bronchoscopy techniques such as endobronchial ultrasound (EBUS) and electromagnetic navigation bronchoscopy. He provides intensive care unit coverage and pulmonary consultations at Piedmont Atlanta Hospital.In his spare time, Dr. Chang enjoys spending time with his family, traveling and sports.Dr. Chang welcomes new patients and accepts most insurance plans.Please note that Dr. Chang does not specialize in sleep medicine. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Liver Failure. His top areas of expertise are Lung Metastases, Pneumonia, Liver Failure, Bronchogenic Cyst, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gowda's expertise for a condition
ConditionClose
      View All 51 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile